🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareIs there a ceiling effect for GLP-1-mediated weight loss? — looking for input Page 2

Is there a ceiling effect for GLP-1-mediated weight loss? — looking for input

VanRx_Mike Sun, Aug 4, 2024 at 4:23 PM 17 replies 2,124 viewsPage 2 of 4
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Aug 5, 2024 at 11:34 AM#6
InsuranceTom said:
Read four things before the headline number.

I read this differently from InsuranceTom, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Aug 5, 2024 at 4:34 PM
35 13denise_HTX, raj_cambridge, ingrid_STO and 32 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Aug 5, 2024 at 7:11 PM#7
VanRx_Mike said:
My own curve sits about four points below the published mean and I spent two months assuming that meant something was wrong with me or with my…
VanRx_Mike said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 12 RCTs (n=8,400) found that the trial evidence was associated with a significant effect size across diverse patient populations[1].

The NNT was 8, which is comparable to antihypertensives for stroke reduction. That's a strong clinical argument for this approach.

Last edited: Aug 5, 2024 at 11:11 PM
36 14NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 33 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Aug 6, 2024 at 2:48 AM#8
NurseKim_ATL said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

37 15maya_sedona, stefan_berlin, Dr.EM_Chicago and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Aug 6, 2024 at 10:24 AM#9

One thing that is still open after PharmHunterJen’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

38 16tane_welly, Dr.PathRoch, mona_PHX and 35 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Aug 7, 2024 at 10:54 PM#10

Reporting back.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

34 9mike_mod, SarahChen_PharmD, sarah.morrison and 31 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register